GlobeNewsWire
18 Jun 2026, 12:46 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
CytoSorbents CEO and CFO will provide a company overview and update at the Life Sciences Forum on June 24, 2026. — Investor presentations can serve as catalysts if new guidance or material updates are shared, though the announcement of the presentation itself is routine.
+0.10The company is scheduling one-on-one meetings with registered investors on June 30, 2026. — Direct management access for institutional investors can increase visibility and sentiment, but has low immediate price impact.
+0.05Which stocks this story touches
The company is proactively engaging with investors through a presentation and one-on-one meetings to provide business updates.
Continue reading
6 related stories
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Proactive Investors
1h ago
